The Usefulness of Postprandial Triglyceride for Assessment of Cardiovascular Risk
NCT ID: NCT01972542
Last Updated: 2015-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2013-06-30
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We aim to investigate the relationship of postprandial triglyceride after fat tolerance test and intima-medial thickness and to suggest normal reference of postprandial triglyceride after fat tolerance test. In addition, we evaluate the correlation of postprandial triglyceride and incretin secretion after fat tolerance test Ultimately, we want to estimate clinical importance of postprandial triglyceride in assessment of cardiovascular risk.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Beneficial Effects of Korean Traditional Diets in Subjects With Hypertension and Type 2 Diabetes
NCT01724645
Effects of Co-ingesting a Low/High GI Meal With Different Fat Saturation on Postprandial Glucose, Insulin, and Triacylglycerol Responses in Healthy Participants
NCT02585427
Postprandial Triglyceride Impact on Coronary Atherosclerosis in Non-Diabetic Patient in Sohag University Hospital
NCT06501287
Impacts of Lentils on Metabolism and Inflammation
NCT04283448
Low Versus High-glycemic Index Post-exercise Diets for Improving Metabolism and Body Composition
NCT03587051
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Type 2 DM
Intervention : Oral fat tolerance test
well or moderately controlled type 2 diabetes mellitus (HbA1c \< 10%) No dipeptidyl peptidase-4 -inhibitor, Glucagon-like peptide-1 agonist, thiazolidinediones
Oral fat tolerance test
Prediabetes
Intervention : Oral fat tolerance test
Glucose 140-199 mg/dL after 75g oral glucose tolerance test HbA1c 5.7-6.4%
Oral fat tolerance test
Normal glucose tolerance
Intervention : Oral fat tolerance test
No impaired fasting glucose and impaired glucose tolerance
Oral fat tolerance test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral fat tolerance test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Type 2 diabetes : HbA1c \<10%
* Prediabetic state : HbA1c 5.7\~6.4%
Exclusion Criteria
* dipeptidyl peptidase-4 -inhibitor, glucagon-like peptide-1 agonist, thiazolidinediones users
* Thyroid disease with abnormal thyroid function test
* Liver disease with abnormal liver function test
* severe kidney disease
* pregnant or lactating women
* current smoker
* severe obesity
19 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soo Lim
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Soo Lim, MD, MPH, PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Bundang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNUBH-ENDO4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.